Baucus will feel pressure for Medicare prescription drug benefit. Kennedy-led Health Committee may supplant Finance as center of legislative activity. Hatch discusses options to fix 180-day exclusivity incentive during May 24 hearing. Apotex pursuing court case to delist six Paxil patents. Pfizer Nifedipine XL Litigation is one subject of FTC industry-wide survey, company discloses in Securities and Exchange Commission filing.
Committee requests more information on dosing, control and congestive heart failure diagnosis.
Pfizer claims increased incidence of heart failure with Cardura is due to decrease in risk for comparator agent. Pfizer's response to NIH trial data prepared for the advisory committee meeting on Cardura . Scios Natrecor Physician Education Program should highlight symptomatic hypotension risk, FDA advisory committee finds. Low-dose of Natrecor recommended for acute decompensated congestive heart failure. Study shows low dose therapy has no advantage over nitroglycerin, committee concludes.